Furthermore, X0 nanobody binding to IgG Fc precludes FcγR binding in vivo, allowing for disruption of pathogenic Fc-FcγR interactions, such as those observed in ADE of dengue virus infection and potentially those driving autoimmune disease25,59,60. The gene discussed is FCGR2A; the disease is dengue disease.